Synthesis and SAR of p38α MAP kinase inhibitors based on heterobicyclic scaffolds

  • T. G. Murali Dhar
  • , Stephen T. Wrobleski
  • , Shuqun Lin
  • , Joseph A. Furch
  • , David S. Nirschl
  • , Yi Fan
  • , Gordon Todderud
  • , Sidney Pitt
  • , Arthur M. Doweyko
  • , John S. Sack
  • , Arvind Mathur
  • , Murray McKinnon
  • , Joel C. Barrish
  • , John H. Dodd
  • , Gary L. Schieven
  • , Katerina Leftheris

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Abstract

The synthesis and structure-activity relationships (SAR) of p38α MAP kinase inhibitors based on heterobicyclic scaffolds are described. This effort led to the identification of compound (21) as a potent inhibitor of p38α MAP kinase with good cellular potency toward the inhibition of TNF-α production. X-ray co-crystallography of an oxalamide analog (24) bound to unphosphorylated p38α is also disclosed.

Original languageEnglish (US)
Pages (from-to)5019-5024
Number of pages6
JournalBioorganic and Medicinal Chemistry Letters
Volume17
Issue number18
DOIs
StatePublished - Sep 15 2007

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'Synthesis and SAR of p38α MAP kinase inhibitors based on heterobicyclic scaffolds'. Together they form a unique fingerprint.

Cite this